Medtronic
Financials
Estimates*
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 30.1b | 31.7b | 31.2b | 32.4b | 33.6b | 35.2b | 36.9b |
| % growth | 4 % | 5 % | (1 %) | 4 % | 4 % | 5 % | 5 % |
| EBITDA | 7.9b | 8.9b | 9.0b | 8.6b | 9.7b | 10.4b | 11.1b |
| % EBITDA margin | 26 % | 28 % | 29 % | 27 % | 29 % | 30 % | 30 % |
| Profit | 3.6b | 5.0b | 3.8b | 3.7b | 5.1b | 5.7b | 6.1b |
| % profit margin | 12 % | 16 % | 12 % | 11 % | 15 % | 16 % | 16 % |
| EV / revenue | 6.6x | 5.2x | 4.6x | 4.0x | 4.0x | 3.8x | 3.5x |
| EV / EBITDA | 25.0x | 18.3x | 15.8x | 15.1x | 13.9x | 12.8x | 11.8x |
| R&D budget | 2.5b | 2.7b | 2.7b | 2.7b | - | - | - |
| R&D % of revenue | 8 % | 9 % | 9 % | 8 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
$20.0m | Post IPO Equity | ||
* | $337m | Post IPO Equity | |
* | N/A | €3.5b | Post IPO Debt |
* | £2.5m | Grant | |
* | $361k | Post IPO Equity | |
* | N/A | $3.0b | Post IPO Debt |
| Total Funding | €3.0m | ||
Related Content
Recent News about Medtronic
EditMedtronic is a global leader in medical technology, services, and solutions. The company operates in over 150 countries, providing innovative healthcare solutions to improve the lives of patients. Medtronic's primary clients include hospitals, clinics, and healthcare professionals who rely on their advanced medical devices and therapies to treat various medical conditions.
Medtronic operates in the healthcare market, focusing on areas such as cardiovascular, diabetes, neurological, and surgical technologies. The company develops and manufactures a wide range of products, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices. These products are designed to diagnose, prevent, and treat chronic diseases and conditions.
The business model of Medtronic revolves around research and development (R&D), manufacturing, and sales of medical devices. The company invests heavily in R&D to innovate and bring new products to market. Once developed, these products are manufactured and distributed to healthcare providers worldwide. Medtronic makes money by selling these medical devices and therapies to hospitals and clinics, which then use them to treat patients.
Medtronic also offers services and solutions that complement their products. These include training for healthcare professionals, patient management programs, and technical support. By providing a comprehensive suite of products and services, Medtronic aims to improve patient outcomes and reduce healthcare costs.
In summary, Medtronic is a key player in the medical technology industry, serving healthcare providers with innovative products and services that address a wide range of medical conditions.
Keywords: medical technology, healthcare, cardiovascular, diabetes, neurological, surgical, devices, innovation, global, patient outcomes.
Tech stack
